Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2025-12-25 @ 9:49 PM
Study NCT ID:
NCT04806451
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-02-05
First Post:
2021-03-16
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Participants With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study)
Sponsor:
Neurocrine Biosciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-25
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-08
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-16
First Submit QC Date:
None
Study First Post Date:
2021-03-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-01-10
Results First Submit QC Date:
None
Results First Post Date:
2025-02-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-03-07
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-01-10
Last Update Post Date:
2025-02-05
Last Update Post Date Type:
ACTUAL